Taken together, these results suggest that lincRNA-p21 plays a critical role in the sesamin-mediated suppression of BC malignancy, primarily through the inhibition of STAT3 signaling and its downstream target--MMP2. The gene discussed is STAT3; the disease is breast cancer.